A scientific overview of the development of AIDS vaccines

The Journal of the Association of Nurses in AIDS Care: JANAC

Volumn 11, Issue 6, 2000, Pages 19-28

  Little, Kevin ^a   Surjadi, Miranda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL; ANTIBODY PRODUCTION; CELLULAR IMMUNITY; DISEASE MODEL; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MEDICAL ETHICS; RESEARCH; REVIEW;

AIDS VACCINES; ANIMALS; ANTIBODY FORMATION; DISEASE MODELS, ANIMAL; ETHICS, MEDICAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; RESEARCH;

EID: 0034329679     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3290(06)60351-8     Document Type: Article

References (46)

1. Ad Hoc Group for the Study of Pertussis Vaccines Placebo-controlled trial of two acellular pertussis vaccines in Sweden–protective efficacy and adverse events The Lancet 1 1988 955 960
2. Andrews L. The pathogenesis of HIV infection M.E. Ropka A.B. Williams HIV nursing and symptom management 1998 Jones and Bartlett Boston 3 35
3. An HIV vaccine: How long must we wait? The Lancet 352 1998 1323
4. Baba T.W. Jeong Y.S. Pennick D. Bronson R. Greene M.F. Ruprecht R.M. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques Science 267 1995 1820 1824
5. Belshe R.B. Graham B.S. Keefer M.C. Gorse G.J. Wright P.W. Dolin R. Matthews T. Weinhold K. Bolognesi D.P. Sposto R. Stablein D.M. Twaddel T. Berman P.W. Gregory T. Izu A.E. Walker M.C. Fast P. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp 120 from the MN strain of HIV-1 Journal of the American Medical Association 272 1994 475 480
6. Bloom B.R. The highest attainable standard: Ethical issues in AIDS vaccines Science 279 1998 186 188
7. Borrow P. Lewicki H. Hahn B. Shaw G. Oldstone M. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection Journal of Virology 68 9 1994 6103 6110
8. Boyer J.D. Ugen K.E. Wang B. Agadjanyan M. Gilbert L. Bagarazzi M.L. Chattergoon M. Frost P. Javadian A. Williams W.V. Refaeli Y. Ciccarelli R.B. McCallus D. Coney L. Weiner D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination Nature Medicine 3 5 1997 526 532
9. Burton D.R. A vaccine for HIV type 1: The antibody perspective Proceedings of the National Academy of Sciences of the United States of America 94 1997 10018 10023
10. Centers for Disease Control and Prevention (CDC) HIV/AIDS surveillance report 1999 Author Atlanta, GA
11. Cocchi F. DeVico A.L. Garnizo-Demo A. Arya S.K. Gallo R.C. Lusso P. Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells Science 270 1995 1811 1815
12. Deacon N.J. Tsykin A. Solomon A. Smith K. Ludford-Menting M. Hooker D.J. McPhee D.A. Greenway A.L. Ellet A. Chatfield C. Lawson V.A. Crowe S. Maerz A. Sonza S. Learmont J. Sullivan J.S. Cunningham A. Dwyer D. Dowton D. Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients Science 270 1995 988 991
13. Esparza J. Heyward W.L. Osmanov S. HIV vaccine development: from basic research to human trials AIDS 10 Suppl. A 1996 S123 S132
14. Evans T.G. Keefer M.C. Weinhold K.J. Wolff M. Montefiori D. Gorse G.J. Graham B.S. McElrath M.J. Clements-Mann M.L. Mulligan M.J. Fast P. Walker M.C. Excler J. Duliege A. Tartaglia J. the NIAID AIDS Vaccine Evaluation Group A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8 cytotoxic T lymphocyte responses in seronegative volunteers The Journal of Infectious Diseases 180 1999 290 298
15. Ferrari G. Humphrey W. McElrath M.J. Excler J.L. Duliege A.M. Clements M.L. Corey L.C. Bolognesi D.P. Weinhold K.J. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers Proceedings of the National Academy of Sciences of the United States of America 94 4 1997 1396 1401
16. Gold D. Newsletter on international AIDS vaccine research IAVI Report 3 4 1998 1 12
17. Gorse J.G. Yang E.Y. Belshe R.B. Berman P.W. Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp 120 vaccine Clinical and Diagnostic Laboratory Immunology 3 1996 769 773
18. Gottlieb S. Where now for AIDS vaccines? British Medical Journal 7152 1998 163
19. Heilman C.A. Baltimore D. HIV vaccines–where are we going? Nature Medicine Supplement 4 5 1998 532 534
20. Heyward W.L. MacQueen K.M. Jaffe H.W. Obstacles and progress toward development of a preventive HIV vaccine Journal of the International Association of Physicians in AIDS Care 3 8 1997 28 34
21. Hu S. Fultz P.N. McClure H.M. Eichberg J.W. Thomas E.K. Zarling J. Singhal M.C. Kosowski S.G. Swenson R.B. Anderson D.C. Todaro G. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees Nature 328 1987 721 725
22. Hulskotte E. Geretti A. Osterhaus A. Towards an HIV-1 vaccine: Lessons from studies in macaque models Vaccine 16 9/10 1998 904 915
23. Johnson R.P. Glickman R.L. Yang J.Q. Kaur A. Dion J.T. Mulligan M.J. Desrosiers R.C. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus Journal of Virology 71 10 1997 7711 7718
24. Kahn J. Culture and medicine: Building and testing an effective HIV vaccine Western Journal of Medicine 171 1999 363 366
25. Kahn J.O. Steimer K.S. Baenziger J. Duliege A.M. Feinberg M. Elbeik T. Chesney M. Murcar N. Chernoff D. Sinangil F. Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial The Journal of Infectious Diseases 171 1995 1343 1347
26. Letvin N.L. Progress in the development of an HIV-1 vaccine Science 280 1998 1875 1880
27. Letvin N.L. King N.W. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques Journal of Acquired Immune Deficiency Syndromes 3 11 1990 1023 1040
28. Letvin N.L. Montefiori D.C. Yasutomi Y. Perry H.C. Davies M. Lekutis C. Alroy M. Freed D.C. Lord C.I. Handt L.K. Liu M.A. Shiver J.W. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination Proceedings of the National Academy of Sciences of the United States of America 94 17 1997 9378 9383
29. Mascola J.R. Snyder S.W. Weislow O.S. Belay S.M. Belshe R.B. Schwartz D.H. Clements M.L. Dolin R. Graham B.S. Gorse G.J. Keefer M.C. McElrath M.J. Walker M.C. Wagner K.F. McNeil J.G. McCutchan F.E. Burke D.S. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1 The Journal of Infectious Diseases 173 1996 340 348
30. Novembre F.J. Saucier M. Anderson D.C. Klumpp S.A. O'Neill S.P. Brown C.R. Hart C.E. Guenthner P.C. Swenson R.B. McClure H.M. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1 Journal of Virology 71 5 1997 4086 4091
31. Pellegrin I. Legrand E. Neau D. Bonot P. Masquelier B. Pellegrin J. Ragnaud J. Bernard N. Fleury H. Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11 1996 438 447
32. Redfield R.R. Wright D.C. James W.D. Jones T.S. Brown C.B. Burke D.S. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease New England Journal of Medicine 316 11 1987 673 676
33. Reimann K.A. Li J.T. Veazey R. Halloran M. Park I. Karlsson G.B. Sodroski J. Letvin N.L. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys Journal of Virology 70 10 1996 6922 6928
34. Steinman R.M. Germain R.N. Antigen presentation and related immunological aspects of HIV-1 vaccines AIDS 1998 12 Suppl. A 1998 S97 S112
35. Stephenson J. AIDS vaccine moves into phase 3 trials Journal of the American Medical Association 280 1 1998 7 8
36. Stott E.J. Anti-cell antibody in macaques Nature 353 1991 393
37. Stott J. Hu S. Vaccines and immunology AIDS 1998 12 Suppl. A 1998 S95 S96
38. Two innovative AIDS vaccine development partnerships launched IAVI Report [On-line] Available: www.iavi.org/newpage/inews.html 1999
39. Wagner R. Teeuwsen V.J. Deml L. Notka F. Haaksma A.G. Jhagjhoorsingh S.S. Niphuis H. Wolf H. Heeney J.L. Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection Virology 245 1 1998 65 74
40. Ward R.L. Bernstein D.I. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines Vaccine 13 13 1995 1226 1232
41. Warren J.T. Levinson M.A. AIDS preclinical vaccine development: biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates Journal of Medical Primatology 28 1999 249 273
42. Whatmore A.M. Cook N. Hall G.A. Sharpe S. Rud E.W. Cranage M.P. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence Journal of Virology 69 8 1995 5117 5123
43. World Health Organization The world health report 1999 [On-line] Available: www.who.int 1999
44. Wyand M.S. Manson K.H. Garcia-Moll M. Montefiori D. Desrosiers R.C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus Journal of Virology 70 6 1996 3724 3733
45. Zolla-Pazner S. Alving C. Belshe R. Berman P. Burda S. Chigurupati P. Clements M.L. Duliege A. Excler J. Hioe C. Kahn J. McElrath M.J. Sharpe S. Sinangil F. Steimer K. Walker M.C. Wassef N. Xu S. Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines Journal of Infectious Diseases 175 1997 764 774
46. Joint United Nations Programme on HIV/AIDS and the World Health Organization UNAIDS/WHO global AIDS statistics AIDS Care 11 5 1999 611 622